{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:51Z","timestamp":1787020971230,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LMS26F020026"],"award-info":[{"award-number":["LMS26F020026"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Age-related eye diseases (AREDs) are leading causes of visual impairment worldwide. With global population aging, understanding their epidemiological trends and socioeconomic disparities is crucial for public health planning and equitable resource allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a secondary epidemiological analysis of AREDs using data from the Global Burden of Disease (GBD) Study 2021. We evaluated years lived with disability (YLDs) and age-standardized YLD rates (ASYR) and conducted trend analysis using Joinpoint regression. Cross-country inequalities were assessed using the slope index of inequality (SII) and concentration index, with correlation and regression analyses examining associations with the socio-demographic index (SDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Global YLDs for AREDs increased from 78.503 to 100.006, while ASYR decreased from 112.815 to 92.803 per 100,000 populations between 1990 and 2021. Despite a global increase in the relative burden of glaucoma, both absolute and relative inequalities for age-related macular degeneration (AMD) and cataracts decreased. Low-SDI countries showed slight improvements in reducing these inequalities. The SII for AREDs improved in lower-SDI countries between 1990 and 2021, with reductions in AMD (from\u2009\u2212\u20099.250 to\u2009\u2212\u20096.033), cataract (from\u2009\u2212\u2009258.131 to\u2009\u2212\u2009173.762), and glaucoma (from\u2009\u2212\u200921.090 to\u2009\u2212\u200920.064). The concentration index for AMD and cataract decreased from\u2009\u2212\u20090.167 and\u2009\u2212\u20090.335 in 1990 to\u2009\u2212\u20090.129 and\u2009\u2212\u20090.272 in 2021, respectively, while the concentration index for glaucoma increased from\u2009\u2212\u20090.208 to\u2009\u2212\u20090.263, Regional disparities in the AREDs burden were evident, with most regions showing improved inequality in lower-SDI countries as reflected in both the SII and concentration index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite global improvements in the relative burden of AREDs, significant socioeconomic and geographical inequalities persist, particularly in low-SDI regions. Targeted public health strategies and strengthened eye care systems are urgently needed to address these disparities and achieve equitable eye health outcomes worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40662-026-00473-5","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:02:38Z","timestamp":1769904158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global burden and cross-country inequalities of age-related eye diseases from 1990 to 2021: a comprehensive analysis of temporal trends and socioeconomic disparities"],"prefix":"10.1186","volume":"13","author":[{"given":"Kuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-7195","authenticated-orcid":false,"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"3","key":"473_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bjo.2003.019927","volume":"88","author":"JR Evans","year":"2004","unstructured":"Evans JR, Fletcher AE, Wormald RP. Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community. Br J Ophthalmol. 2004;88(3):365\u201370.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"473_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/msj.21303","volume":"79","author":"JW Eichenbaum","year":"2012","unstructured":"Eichenbaum JW. Geriatric vision loss due to cataracts, macular degeneration, and glaucoma. Mt Sinai J Med. 2012;79(2):276\u201394.","journal-title":"Mt Sinai J Med"},{"issue":"5","key":"473_CR3","first-page":"2803","volume":"16","author":"L You","year":"2024","unstructured":"You L, Lin Y, Zheng Y, Han Z, Zeng L, Chen H. The impact of aging on ocular diseases: unveiling complex interactions. Aging Dis. 2024;16(5):2803\u201330.","journal-title":"Aging Dis"},{"issue":"14","key":"473_CR4","doi-asserted-by":"publisher","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","volume":"54","author":"R Klein","year":"2013","unstructured":"Klein R, Klein BE. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci. 2013;54(14):ORSF5\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"473_CR5","unstructured":"World Health Organization. World report on vision. https:\/\/www.who.int\/publications\/i\/item\/9789241516570. Accessed June 2025."},{"key":"473_CR6","unstructured":"Think Global Health.\u00a0Putting Vision Loss and Aging into Focus. https:\/\/www.thinkglobalhealth.org\/article\/putting-vision-loss-and-aging-focus. Accessed June 2025."},{"issue":"2","key":"473_CR7","first-page":"e130","volume":"9","author":"GBD 2019 Blindness and vision impairment collaborators, vision loss expert group of the global burden of disease study","year":"2021","unstructured":"GBD 2019 Blindness and vision impairment collaborators, vision loss expert group of the global burden of disease study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e130\u201343.","journal-title":"Eye (Lond)"},{"issue":"4","key":"473_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF03324611","volume":"17","author":"JM Jacobs","year":"2005","unstructured":"Jacobs JM, Hammerman-Rozenberg R, Maaravi Y, Cohen A, Stessman J. The impact of visual impairment on health, function and mortality. Aging Clin Exp Res. 2005;17(4):281\u20136.","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"473_CR9","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/jgs.14458","volume":"64","author":"A Hajek","year":"2016","unstructured":"Hajek A, Brettschneider C, L\u00fchmann D, Eisele M, Mamone S, Wiese B, et al. Effect of visual impairment on physical and cognitive function in old age: findings of a population-based prospective cohort study in Germany. J Am Geriatr Soc. 2016;64(11):2311\u20136.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"473_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jcrs.2019.02.006","volume":"45","author":"GC Brown","year":"2019","unstructured":"Brown GC, Brown MM, Busbee BG. Cost-utility analysis of cataract surgery in the United States for the year 2018. J Cataract Refract Surg. 2019;45(7):927\u201338.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"473_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/bjo.2003.035279","volume":"88","author":"C Hopley","year":"2004","unstructured":"Hopley C, Salkeld G, Wang JJ, Mitchell P. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Br J Ophthalmol. 2004;88(4):450\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"473_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/sj.eye.6702637","volume":"22","author":"A Peeters","year":"2008","unstructured":"Peeters A, Schouten JS, Webers CA, Prins MH, Hendrikse F, Severens JL. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist. Eye (Lond). 2008;22(3):354\u201362.","journal-title":"Eye (Lond)"},{"issue":"1","key":"473_CR13","first-page":"36","volume":"33","author":"Vision Loss Expert Group of The Global Burden of Disease Study, The Gbd Blindness and Vision Impairment Collaborators","year":"2025","unstructured":"Vision Loss Expert Group of The Global Burden of Disease Study, The Gbd Blindness and Vision Impairment Collaborators. Prevalence of vision loss in Latin America and the Caribbean in 2020: magnitude and temporal trends. Ophthalmic Epidemiol. 2025;33(1):36\u201342.","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"473_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2003.05.011","volume":"111","author":"WM Hsu","year":"2004","unstructured":"Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004;111(1):62\u20139.","journal-title":"Ophthalmology"},{"issue":"2","key":"473_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaophthalmol.2022.5840","volume":"141","author":"OJ Killeen","year":"2023","unstructured":"Killeen OJ, De Lott LB, Zhou Y, Hu M, Rein D, Reed N, et al. Population prevalence of vision impairment in US adults 71 years and older: The National Health and Aging Trends Study. JAMA Ophthalmol. 2023;141(2):197\u2013204.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"473_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s43587-022-00298-6","volume":"2","author":"JR Ehrlich","year":"2022","unstructured":"Ehrlich JR, Agarwal A, Young C, Lee J, Bloom DE. The prevalence of vision impairment and blindness among older adults in India: findings from the Longitudinal Ageing Study in India. Nat Aging. 2022;2(11):1000\u20137.","journal-title":"Nat Aging"},{"key":"473_CR17","doi-asserted-by":"publisher","first-page":"1324141","DOI":"10.3389\/fpubh.2024.1324141","volume":"12","author":"J Yin","year":"2024","unstructured":"Yin J, Jiang B, Zhao T, Guo X, Tan Y, Wang Y. Trends in the global burden of vision loss among the older adults from 1990 to 2019. Front Public Health. 2024;12:1324141.","journal-title":"Front Public Health"},{"issue":"11","key":"473_CR18","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41433-024-02995-5","volume":"38","author":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators","year":"2024","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by glaucoma: a meta-analysis from 2000 to 2020. Eye (Lond). 2024;38(11):2036\u201346.","journal-title":"Eye (Lond)"},{"issue":"10440","key":"473_CR19","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"473_CR20","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"2","key":"473_CR21","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study","year":"2021","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144\u201360.","journal-title":"Lancet Glob Health"},{"issue":"10258","key":"473_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"10159","key":"473_CR23","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"key":"473_CR24","first-page":"e068208","volume":"376","author":"GBD 2019 Ageing Collaborators","year":"2022","unstructured":"GBD 2019 Ageing Collaborators. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022;376:e068208.","journal-title":"BMJ"},{"issue":"10136","key":"473_CR25","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/S0140-6736(18)30994-2","volume":"391","author":"GBD 2016 Healthcare Access and Quality Collaborators","year":"2018","unstructured":"GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236\u201371.","journal-title":"Lancet"},{"issue":"10053","key":"473_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545\u2013602.","journal-title":"Lancet"},{"key":"473_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063697","author":"A Schlotheuber","year":"2022","unstructured":"Schlotheuber A, Hosseinpoor AR. Summary measures of health inequality: a review of existing measures and their application. Int J Environ Res Public Health. 2022;19(6):3697.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"473_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12963-024-00347-9","volume":"22","author":"B Devleesschauwer","year":"2024","unstructured":"Devleesschauwer B, Charalampous P, Gorasso V, Assun\u00e7\u00e3o R, Hilderink H, Idavain J, et al. Standardised reporting of burden of disease studies: the STROBOD statement. Popul Health Metr. 2024;22(1):28.","journal-title":"Popul Health Metr"},{"key":"473_CR29","unstructured":"National Cancer Institute.\u00a0Joinpoint Trend Analysis Software (Version 5.3.0). https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed Nov 2024."},{"key":"473_CR30","first-page":"102829","volume":"76","author":"Z Luo","year":"2024","unstructured":"Luo Z, Shan S, Cao J, Zhou J, Zhou L, Jiang D, et al. Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021. EClin Med. 2024;76:102829.","journal-title":"EClin Med"},{"key":"473_CR31","doi-asserted-by":"publisher","first-page":"29034","DOI":"10.3402\/gha.v8.29034","volume":"8","author":"AR Hosseinpoor","year":"2015","unstructured":"Hosseinpoor AR, Bergen N, Schlotheuber A. Promoting health equity: WHO health inequality monitoring at global and national levels. Glob Health Action. 2015;8:29034.","journal-title":"Glob Health Action"},{"issue":"4","key":"473_CR32","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00431-024-05450-5","volume":"183","author":"J Chen","year":"2024","unstructured":"Chen J, Zhu Y, Li L, Lv J, Li Z, Chen X, et al. Visual impairment burden in retinopathy of prematurity: trends, inequalities, and improvement gaps. Eur J Pediatr. 2024;183(4):1891\u2013900.","journal-title":"Eur J Pediatr"},{"issue":"10","key":"473_CR33","doi-asserted-by":"publisher","first-page":"e1388","DOI":"10.1016\/S2214-109X(19)30360-2","volume":"7","author":"P Ordunez","year":"2019","unstructured":"Ordunez P, Martinez R, Soliz P, Giraldo G, Mujica OJ, Nordet P. Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990\u20132017: a population-based study. Lancet Glob Health. 2019;7(10):e1388\u201397.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"473_CR34","doi-asserted-by":"publisher","first-page":"103326","DOI":"10.1016\/j.autrev.2023.103326","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"473_CR35","first-page":"473","volume":"3","author":"R Ehrlich","year":"2008","unstructured":"Ehrlich R, Harris A, Kheradiya NS, Winston DM, Ciulla TA, Wirostko B. Age-related macular degeneration and the aging eye. Clin Interv Aging. 2008;3(3):473\u201382.","journal-title":"Clin Interv Aging"},{"key":"473_CR36","doi-asserted-by":"publisher","first-page":"1110383","DOI":"10.3389\/fmed.2023.1110383","volume":"10","author":"R Mencucci","year":"2023","unstructured":"Mencucci R, Stefanini S, Favuzza E, Cennamo M, De Vitto C, Mossello E. Beyond vision: cataract and health status in old age, a narrative review. Front Med (Lausanne). 2023;10:1110383.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"473_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.14336\/AD.2023.0630-1","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Huang S, Xie B, Zhong Y. Aging, cellular senescence, and glaucoma. Aging Dis. 2024;15(2):546\u201364.","journal-title":"Aging Dis"},{"issue":"2","key":"473_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ajo.2011.10.016","volume":"153","author":"SB Bloch","year":"2012","unstructured":"Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153(2):209\u201313.e2.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"473_CR39","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41433-020-0864-6","volume":"34","author":"F Rahman","year":"2020","unstructured":"Rahman F, Zekite A, Bunce C, Jayaram H, Flanagan D. Recent trends in vision impairment certifications in England and Wales. Eye (Lond). 2020;34(7):1271\u20138.","journal-title":"Eye (Lond)"},{"issue":"11","key":"473_CR40","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s41433-024-03050-z","volume":"38","author":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators","year":"2024","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020. Eye (Lond). 2024;38(11):2070\u201382.","journal-title":"Eye (Lond)"},{"issue":"12","key":"473_CR41","doi-asserted-by":"publisher","first-page":"e1744","DOI":"10.1016\/S2214-109X(22)00419-3","volume":"10","author":"I McCormick","year":"2022","unstructured":"McCormick I, Butcher R, Evans JR, Mactaggart IZ, Limburg H, Jolley E, et al. Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries. Lancet Glob Health. 2022;10(12):e1744\u201353.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"473_CR42","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/s41433-024-02961-1","volume":"38","author":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators","year":"2024","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study, GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye (Lond). 2024;38(11):2156\u201372.","journal-title":"Eye (Lond)"},{"key":"473_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s12539-025-00763-x","author":"S Bao","year":"2025","unstructured":"Bao S, Yang Z, Zhang Z, Qu J, Sun J. AttResAMD: an attention-driven deep learning framework for expert-level automated classification of age-related macular degeneration from fundus photography. Interdiscip Sci. 2025. https:\/\/doi.org\/10.1007\/s12539-025-00763-x.","journal-title":"Interdiscip Sci"},{"issue":"9","key":"473_CR44","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018;24(9):1342\u201350.","journal-title":"Nat Med"},{"issue":"1","key":"473_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40662-024-00378-1","volume":"11","author":"VHX Foo","year":"2024","unstructured":"Foo VHX, Lim GYS, Liu YC, Ong HS, Wong E, Chan S, et al. Deep learning for detection of Fuchs endothelial dystrophy from widefield specular microscopy imaging: a pilot study. Eye Vis (Lond). 2024;11(1):11.","journal-title":"Eye Vis (Lond)"},{"issue":"2","key":"473_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/j.jcrs.0000000000001571","volume":"51","author":"A Hanna","year":"2025","unstructured":"Hanna A, Martinez DL, Popovic M, Ahmed IIK, Teichman J. Virtual follow-up after cataract surgery: systematic review. J Cataract Refract Surg. 2025;51(2):167\u201374.","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"473_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2021.12.017","volume":"129","author":"TDL Keenan","year":"2022","unstructured":"Keenan TDL, Chen Q, Agron E, Tham YC, Goh JHL, Lei X, et al. DeepLensNet: deep learning automated diagnosis and quantitative classification of cataract type and severity. Ophthalmology. 2022;129(5):571\u201384.","journal-title":"Ophthalmology"},{"issue":"12","key":"473_CR48","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jamaophthalmol.2019.3501","volume":"137","author":"H Liu","year":"2019","unstructured":"Liu H, Li L, Wormstone IM, Qiao C, Zhang C, Liu P, et al. Development and validation of a deep learning system to detect glaucomatous optic neuropathy using fundus photographs. JAMA Ophthalmol. 2019;137(12):1353\u201360.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"473_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40662-025-00440-6","volume":"12","author":"ZJ Muhsin","year":"2025","unstructured":"Muhsin ZJ, Qahwaji R, Ghafir I, AlShawabkeh M, Al Bdour M, AlRyalat SA, et al. Highly efficient stacking ensemble learning model for automated keratoconus screening. Eye Vis (Lond). 2025;12(1):25.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"473_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40662-024-00373-6","volume":"11","author":"Y Ren","year":"2024","unstructured":"Ren Y, Wen H, Bai F, Huang B, Wang Z, Zhang S, et al. Comparison of deep learning-assisted blinking analysis system and Lipiview interferometer in dry eye patients: a cross-sectional study. Eye Vis (Lond). 2024;11(1):7.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"473_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40662-024-00405-1","volume":"11","author":"S Wang","year":"2024","unstructured":"Wang S, He X, Jian Z, Li J, Xu C, Chen Y, et al. Advances and prospects of multi-modal ophthalmic artificial intelligence based on deep learning: a review. Eye Vis (Lond). 2024;11(1):38.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"473_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40662-024-00396-z","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang Z, Guo X, Jin W, Lin D, Chen A, et al. Automated early detection of acute retinal necrosis from ultra-widefield color fundus photography using deep learning. Eye Vis (Lond). 2024;11(1):27.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"473_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40662-024-00389-y","volume":"11","author":"J Yao","year":"2024","unstructured":"Yao J, Lim J, Lim GYS, Ong JCL, Ke Y, Tan TF, et al. Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema. Eye Vis (Lond). 2024;11(1):23.","journal-title":"Eye Vis (Lond)"},{"issue":"23","key":"473_CR54","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1001\/jama.2025.1597","volume":"333","author":"SP Chen","year":"2025","unstructured":"Chen SP, Woreta F, Chang DF. Cataracts: a review. JAMA. 2025;333(23):2093-103.","journal-title":"JAMA"},{"issue":"6","key":"473_CR55","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jcrs.2016.04.013","volume":"42","author":"PC Gupta","year":"2016","unstructured":"Gupta PC, Ram J. Long-term outcomes of cataract surgery: 15-year results of a prospective study. J Cataract Refract Surg. 2016;42(6):944.","journal-title":"J Cataract Refract Surg"},{"issue":"10414","key":"473_CR56","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788\u2013801.","journal-title":"Lancet"},{"issue":"10","key":"473_CR57","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","volume":"43","author":"NM Schultz","year":"2021","unstructured":"Schultz NM, Bhardwaj S, Barclay C, Gaspar L, Schwartz J. Global burden of dry age-related macular degeneration: a targeted literature review. Clin Ther. 2021;43(10):1792\u2013818.","journal-title":"Clin Ther"},{"issue":"7","key":"473_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/pharmaceutics14071473","volume":"14","author":"Y Jim\u00e9nez-G\u00f3mez","year":"2022","unstructured":"Jim\u00e9nez-G\u00f3mez Y, Alba-Molina D, Blanco-Blanco M, P\u00e9rez-Fajardo L, Reyes-Ortega F, Ortega-Llamas L, et al. Novel treatments for age-related macular degeneration: a review of clinical advances in sustained drug delivery systems. Pharmaceutics. 2022;14(7):1473.\u00a0","journal-title":"Pharmaceutics"},{"issue":"3","key":"473_CR59","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1111\/aos.16790","volume":"103","author":"L Gayraud","year":"2025","unstructured":"Gayraud L, Mortamais M, Schweitzer C, de Hoogh K, Cougnard-Gr\u00e9goire A, Korobelnik JF, et al. Ambient air pollution exposure and incidence of cataract surgery: the prospective 3City-Alienor study. Acta Ophthalmol. 2025;103(3):e192\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"473_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1289\/EHP193","volume":"124","author":"TD Ravilla","year":"2016","unstructured":"Ravilla TD, Gupta S, Ravindran RD, Vashist P, Krishnan T, Maraini G, et al. Use of cooking fuels and cataract in a population-based study: the India Eye Disease Study. Environ Health Perspect. 2016;124(12):1857\u201362.","journal-title":"Environ Health Perspect"},{"issue":"6","key":"473_CR61","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.3390\/ijms23063269","volume":"23","author":"R Nuzzi","year":"2022","unstructured":"Nuzzi R, Caselgrandi P. Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience. Int J Mol Sci. 2022;23(6):3269.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"473_CR62","doi-asserted-by":"publisher","first-page":"e0235699","DOI":"10.1371\/journal.pone.0235699","volume":"15","author":"J Wilkinson","year":"2020","unstructured":"Wilkinson J, Mailu EW, Virendrakumar B, Bechange S, Jolley E, Schmidt E. Factors associated with the uptake of cataract surgery and interventions to improve uptake in low- and middle-income countries: a systematic review. PLoS One. 2020;15(7):e0235699.","journal-title":"PLoS ONE"},{"issue":"1","key":"473_CR63","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12913-020-05279-2","volume":"20","author":"S Bechange","year":"2020","unstructured":"Bechange S, Jolley E, Virendrakumar B, Pente V, Milgate J, Schmidt E. Strengths and weaknesses of eye care services in sub-Saharan Africa: a meta-synthesis of eye health system assessments. BMC Health Serv Res. 2020;20(1):381.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"473_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamaophthalmol.2018.0597","volume":"136","author":"J Foreman","year":"2018","unstructured":"Foreman J, Keel S, van Wijngaarden P, Bourne RA, Wormald R, Crowston J, et al. Prevalence and causes of visual loss among the indigenous peoples of the world: a systematic review. JAMA Ophthalmol. 2018;136(5):567\u201380.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"473_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13756-022-01071-5","volume":"11","author":"A Davis","year":"2022","unstructured":"Davis A, Lembo T, Laurie E, Mutua E, Loosli K, Nthambi M, et al. How public health crises expose systemic, day-to-day health inequalities in low-and-middle income countries: an example from East Africa. Antimicrob Resist Infect Control. 2022;11(1):34.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"473_CR66","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40506-020-00229-2","volume":"12","author":"K Jayatilleke","year":"2020","unstructured":"Jayatilleke K. Challenges in implementing surveillance tools of high-income countries (HICs) in low middle income countries (LMICs). Curr Treat Options Infect Dis. 2020;12(3):191\u2013201.","journal-title":"Curr Treat Options Infect Dis"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-026-00473-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:02:40Z","timestamp":1769904160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40662-026-00473-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/s40662-026-00473-5","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}